|   | ![]() Your Search for Peripheral Neuropathy matched 1000 Documents (Page 1 of 34). You may want to refine your search. Results Indexed by relevance. |
| 1. |
AEGiS OI: Peripheral Neuropathy (100%) Abstract: The most common symptom is severe, burning, aching pain in the feet and legs, which may prevent walking. ... http://www.aegis.com/topics/oi/oi-neuropathy.html File Name: oi-neuropathy.html, Size: 7KB, Last Modified: Monday, January 12, 2009 at 9:53:40 PM |
| 2. |
[Peripheral neuropathy in relation to LAV/HTLV III retrovirus infection. A clinical, anatomical and immunological study. 5 cases] (100%) Abstract: An unexplained peripheral neuropathy was observed in five patients with positive serology for LAV/HTLV III. Three of them presented with polyneuropathy, one with chronic meningitis and oculomotor palsies, and one with a mononeuropathy. CSF was abnormal in 5/5, with el ... http://www.aegis.com/news/ine/1987/may/m8750059.html File Name: m8750059.html, Size: 9KB, Last Modified: Wednesday, January 07, 2009 at 5:05:08 AM |
| 3. |
AEGiS-15CROI [988]: Outcome of Stavudine-induced Peripheral Neuropathy in HIV-infected Individuals in Rural Uganda (100%) Abstract: For people with mild symptoms of d4T-associated peripheral neuropathy, improvement was common without drug substitution. For people with severe neuropathy, most improved after a drug substitution with AZT, although improvement was more likely with baseline CD4 cell counts >200 cells/µL. ... http://www.aegis.com/conferences/croi/2008/988.html File Name: 988.html, Size: 7KB, Last Modified: Sunday, February 03, 2008 at 7:12:04 PM |
| 4. |
[51] A pilot study of chip-based whole mitochondrial genome sequencing in a subgroup of participants from AIDS Clinical Trials Group (ACTG) Study 384 (100%) Abstract: Chip-based whole mtDNA sequencing is technically feasible, was able to accurately haplogroup these HIV-infected individuals, and identified several known and potentially novel SNPs. In this small sample, the initial 7 mtDNA SNPs explored were not associated with NRTI-associated peripheral neuropathy. This technology co ... http://www.aegis.com/conferences/lipo/2006/51.html File Name: 51.html, Size: 7KB, Last Modified: Monday, September 25, 2006 at 6:29:23 AM |
| 5. |
Simple FactSheet: zalcitabine, (ddC, Hivid) (100%) Abstract: zalcitabine, (ddC, Hivid) ... http://www.aegis.com/factshts/network/simple/zalc.html File Name: zalc.html, Size: 11KB, Last Modified: Sunday, August 20, 2006 at 9:21:39 PM |
| 6. |
Simple FactSheet: peripheral neuropathy (100%) Abstract: What is Peripheral neuropathy? HIV drugs that can cause peripheral neuropathy, current treatments, relieving the pain, nutrients and peripheral neuropathy, on-going clinical trials ... http://www.aegis.com/factshts/network/simple/neurop.html File Name: neurop.html, Size: 12KB, Last Modified: Sunday, August 20, 2006 at 9:21:19 PM |
| 7. |
[ThPE0120] META-ANALYSIS OF EFFICACY AND SAFETY FOR CLINICAL STUDIES OF D4T 40MG VERSUS 30MG BID IN 1008 PATIENTS (100%) Abstract: In this meta-analysis, d4T 40mg and 30mg BID showed equivalent antiviral efficacy by standard US FDA criteria. In cohort studies, the incidence of peripheral neuropathy and lipoatrophy was lower at the 30mg BID dosage. ... http://www.aegis.com/conferences/iac/2006/thpe0120.html File Name: thpe0120.html, Size: 9KB, Last Modified: Sunday, August 13, 2006 at 7:00:01 AM |
| 8. |
AEGiS-13CROI [350]: Non-synonymous Mitochondrial DNA Polymorphisms and Peripheral Neuropathy during NRTI Therapy in ACTG Study 384 (100%) Abstract: T4216C and A4917G, 2 non-synonymous mitochondrial DNA polymorphisms, were frequent among white ACTG 384 participants, and were associated with the development of peripheral neuropathy among those individuals randomized to receive ddI+d4T. These polymorphisms are known to alter amino acids in mitochondrial complex I sub ... http://www.aegis.com/conferences/croi/2006/350.html File Name: 350.html, Size: 8KB, Last Modified: Sunday, February 05, 2006 at 8:12:04 PM |
| 9. |
AEGiS-13CROI [769]: Early, Uninterrupted ART Is Associated with Improved Outcomes and Fewer Toxicities in the HIV Outpatient Study (HOPS) (100%) Abstract: HOPS patients with higher pre-HAART CD4+ cell counts were less likely to develop renal insufficiency, peripheral neuropathy, and lipoatrophy in the HAART era, suggesting the benefit of earlier HAART treatment. Our findings also raise the possibility that use of HAART without interruptions may reduce the incidence of th ... http://www.aegis.com/conferences/croi/2006/769.html File Name: 769.html, Size: 8KB, Last Modified: Sunday, February 05, 2006 at 8:12:04 PM |
| 10. |
AEGiS-13CROI [78]: Hemochromatosis Gene Polymorphisms and Peripheral Neuropathy during ART: Analysis NWCS 238 of ACTG Study 384 (100%) Abstract: Iron-loading HFE polymorphisms may be associated with a decreased risk of NRTI-associated peripheral neuropathy. This finding has potential implications for the prevention and management of NRTI-associated peripheral neuropathy, particularly among populations at risk for iron deficiency. Further study of functional mec ... http://www.aegis.com/conferences/croi/2006/78.html File Name: 78.html, Size: 8KB, Last Modified: Sunday, February 05, 2006 at 8:12:04 PM |
| 11. |
AEGiS-12CROI: A Pilot Study of Mitochondrial Haplogroups and Peripheral Neuropathy during Antiretroviral Therapy: NWCS238, an Analysis of ACTG Study 384 (100%) Abstract: Mitochondrial haplogroup T was more frequent in Caucasians who developed subjective peripheral neuropathy while on ddI/d4T during Study 384. The polymorphism that defines this haplogroup is located in the ND5 region of the mitochondrial gene encoding Complex I respiratory transport chain subunits and may point to varia ... http://www.aegis.com/conferences/croi/2005/43.html File Name: 43.html, Size: 8KB, Last Modified: Tuesday, February 22, 2005 at 8:12:04 PM |
| 12. |
AEGiS-12CROI: EXPERIMENTAL DENERVATION OF THE EPIDERMIS DEMONSTRATED REDUCED REGERATION OF OCICEPTICE FIBERS IN PEOPLE WITH HIV (100%) Abstract: Nerve regeneration occurs and can be rigorously measured over a period of several months in HIV+ subjects. Our results suggest that abnormalities in nerve regeneration precede the development of clinical neuropathy. Regeneration rates for HIV subjects are impaired compared to healthy control subjects and this differenc ... http://www.aegis.com/conferences/croi/2005/13.html File Name: 13.html, Size: 8KB, Last Modified: Tuesday, February 22, 2005 at 8:12:04 PM |
| 13. |
AEGiS-12CROI: HIV Neuropathy Natural History Cohort Study: Clinical and Laboratory Features, and Risk Factors for Progression: ACTG A5117 (100%) Abstract: Peripheral neuropathy remains highly prevalent in HIV infection, and its course was relatively stable over 48 weeks. Previously established risk factors for peripheral neuropathy, including CD4 and HIV RNA, were not predictive for the presence or progression of neuropathy. While use of d-drugs did not predict progressi ... http://www.aegis.com/conferences/croi/2005/397.html File Name: 397.html, Size: 9KB, Last Modified: Tuesday, February 22, 2005 at 8:12:04 PM |
| 14. |
AEGiS-12CROI: Peripheral Neuropathy and Oxidant Stress during ART: NWCS230, an Analysis of ACTG Study 384 (100%) Abstract: Plasma F2-IsoP levels were unexpectedly high at baseline in cryopreserved specimens from these study subjects compared to levels from a previous study that included HIV-infected adults not receiving ART. This may reflect ex vivo auto-oxidation of some plasma specimens. Although F2-IsoP increases tended to be somewhat g ... http://www.aegis.com/conferences/croi/2005/399.html File Name: 399.html, Size: 9KB, Last Modified: Tuesday, February 22, 2005 at 8:12:04 PM |
| 15. |
AEGiS-15IAC: Acupuncture in a group setting reduces the pain and neuropathic symptoms associated with HIV infection. (100%) Abstract: BACKGROUND: Pain and peripheral neuropathy are prevalent symptoms of HIV/AIDS that often do not respond to allopathic medical therapy. The present study was performed to determine the effect of 5 weeks of acupuncture treatment in a group setting on pain and symptoms of peripheral neuropathy in HIV-infected individuals. ... http://www.aegis.com/conferences/iac/2004/b11024.html File Name: b11024.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 16. |
AEGiS-15IAC: Safety and tolerability of didanosine combined with tenofovir DF in ambulatory HIV-1 infected adult individuals. (100%) Abstract: Objectives: Evaluate the safety and tolerability of ddI/TDF in ARV for HIV-infected adults in the HOPS cohort. METHODS: Subjects identified using an electronic database of patients at 9 US clinics who received >14 days of ddI/TDF prior to Oct 2003. Adverse events that were examined in this analysis were ... http://www.aegis.com/conferences/iac/2004/wepeb5922.html File Name: wepeb5922.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 17. |
AEGiS-11CROI: Peripheral Neuropathy Associated with HIV and ARV: Update on Diagnosis and Management (100%) Abstract: Pathogenesis-based therapies may provide both analgesic and restorative effects in peripheral neuropathy. Recombinant human nerve growth factor produced pain relief in HIV neuropathy, but did not show regenerative effects. Within the ACTG, a novel agent, Prospatide, is under study for HIV neuropathy (A5180). Other agen ... http://www.aegis.com/conferences/croi/2004/34.html File Name: 34.html, Size: 8KB, Last Modified: Sunday, February 08, 2004 at 8:12:04 PM |
| 18. |
SIDE-EFFECTS OF ANTIRETROVIRAL THERAPY IN GREEK HIV-POSITIVE POPULATION CAUSING DRUG INTERRUPTION: A COHORT STUDY (100%) Abstract: Adverse events, which lead to treatment interruption or change are frequent (37,3%). NRTIs are more frequently responsible for bone marrow suppression, peripheral neuropathy and diarrhea, Pis for gastrointestinal disorders, lipodystrophy, renal colic and nephrolithiasis and NNRTIs for allergic reactions. ... http://www.aegis.com/conferences/eacs/2001/posters/491.html File Name: 491.html, Size: 8KB, Last Modified: Tuesday, December 23, 2003 at 4:41:41 PM |
| 19. |
SIDE-EFFECTS OF ANTIRETROVIRAL THERAPY IN GREEK HIV-POSITIVE POPULATION CAUSING DRUG INTERRUPTION: A COHORT STUDY (100%) Abstract: AEGIS, 8th EUROPEAN CONFERENCE ON CLINIC ASPECTS AND TREATMENT OF HIV - INFECTION. Abstract Form. REFERENCE NUMBER : 395. ECCATH ID : P260. 8th EUROPEAN CONFERENCE ON CLINIC ASPECTS AND TREATMENT OF HIV - INFECTION. Location of research or project (country). Greece. Thematic Areas:. Title. SIDE-EFFECTS OF ANTIRETRO ... http://www.aegis.com/conferences/eacs/2001/papers/491.html File Name: 491.html, Size: 7KB, Last Modified: Monday, December 01, 2003 at 5:53:50 AM |
| 20. |
AEGiS-PRn: Market for Peripheral Neuropathy Among Diabetics, HIV/AIDS and Cancer Patients Approaches $1B by 2012 (100%) Abstract: SAN FRANCISCO, Nov. 20 /PRNewswire/ -- Prevention and reversal of damage to peripheral nerves -- peripheral neuropathy -- continues to confound clinicians and their patients worldwide. More than one million people in the U.S., Europe, and Japan suffer the symptoms of this frequently under-diagnosed and irreversi ... http://www.aegis.com/news/pr/2003/pr031142.html File Name: pr031142.html, Size: 10KB, Last Modified: Thursday, November 20, 2003 at 3:00:00 PM |
| 21. |
[48] IS NUCLEOSIDE ANALOGUE-ASSOCIATED PERIPHERAL NEUROPATHY A CUMULATIVE TOXIC PROCESS? (100%) Abstract: We found no evidence of a cumulative toxicity in any of the study arms. Age and CD4 were independently associated with peripheral neuropathy. ... http://www.aegis.com/conferences/lipo/2003/48.html File Name: 48.html, Size: 6KB, Last Modified: Wednesday, July 09, 2003 at 6:29:23 AM |
| 22. |
AEGiS-14IAC: Peripheral neuropathy in HIV-1 adult infected patients using Stavudine and Didanosine in a combination therapy with Efavirenz. (100%) Abstract: <p><b>BACKGROUND:</b> Stavudine and Didanosine are two nucleoside analogues. Their efficacy in antiretroviral combination therapy was largely demonstrated by many clinical trials. ... http://www.aegis.com/conferences/iac/2002/mopeb3240.html File Name: mopeb3240.html, Size: 8KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM |
| 23. |
HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. (100%) Abstract: Peripheral neuropathy is the most frequent neurological complication associated with human immunodeficiency virus type 1 (HIV) infection and advanced acquired immunodeficiency syndrome (AIDS). There are at least 6 patterns of HIV-associated peripheral neuropathy , alth ... http://www.aegis.com/aidsline/2000/dec/a00c0215.html File Name: a00c0215.html, Size: 10KB, Last Modified: Thursday, December 28, 2000 at 8:12:04 PM |
| 24. |
Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. (100%) Abstract: BACKGROUND: Peripheral neuropathy in children with human immunodeficiency virus (HIV) infection has not been systematically studied. Objectives. To describe the symptoms and signs of peripheral neuropathy in HIV-infected children and to determine their frequency. METH ... http://www.aegis.com/pubs/ine/2000/nov/a00b0244.html File Name: a00b0244.html, Size: 9KB, Last Modified: Tuesday, November 28, 2000 at 8:12:04 PM |
| 25. |
AEGiS-Glasgow [P169] HIV RELATED PERIPHERAL NEUROPATHY TREATED WITH GABAPENTIN IN GLASGOW (100%) Abstract: In our patient cohort gabapentin at a daily dose of 0.9–1.8 g is effective in the symptomatic treatment of HIV-related peripheral neuropathy when CD4 counts are > 200/cmm. Our findings support the suggestion that higher doses may be necessary in advanced HIV disease (CD4 < 200/cmm) [4] ... http://www.aegis.com/conferences/hiv-glasgow/2000/p169.html File Name: p169.html, Size: 7KB, Last Modified: Sunday, October 22, 2000 at 8:12:04 PM |
| 26. |
[P16] Increased antiretroviral therapy therapy experience in zidovudine-naïve subjects failing on a stavudine-containing regimen was significantly associated with peripheral neuropathy and wasting syndrome (100%) Abstract: Zidovudine-naïve subjects failing on a stavudine-containing regimen with CDC classification C illnesses were significantly more likely to have higher HIV-1 RNA levels. More heavily ART-experienced subjects (more than four prior ART) had significantly increased incidence of peripheral neuropathy and wasting syndrome. ... http://www.aegis.com/conferences/lipo/2000/p16.html File Name: p16.html, Size: 6KB, Last Modified: Thursday, September 14, 2000 at 6:29:23 AM |
| 27. |
AEGiS-13IAC: Self-care for peripheral neuropathy in HIV disease. (100%) Abstract: <p><b>BACKGROUND:</b> People living with HIV/AIDS experience perpheral neuropathy due to HIV disease, side effects of medication and treatment, and co-morbidities. This study describes the frequency and correlates (demographic and disease-related factors) of self-reported neuropathy and the self-care behaviors used t ... http://www.aegis.com/conferences/iac/2000/thpeb5250.html File Name: thpeb5250.html, Size: 7KB, Last Modified: Sunday, July 09, 2000 at 8:12:04 PM |
| 28. |
Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. (100%) Abstract: Peripheral neuropathy has been recognized as a dose-limiting adverse effect in Phase I studies of didanosine (ddI) therapy for HIV infection. To study the effect of the currently recommended lower dose of ddI, the databases of 4 randomized, controlled trials were used to assess the frequency of dose-limiting ... http://www.aegis.com/aidsline/2000/jan/a0010932.html File Name: a0010932.html, Size: 11KB, Last Modified: Friday, January 28, 2000 at 8:12:04 PM |
| 29. |
[Electroneuromyography and somatosensory evoked potentials in HTLV-I associated myelopathy] (100%) Abstract: The objective of the present study was to correlate electroneuromyography (ENMG) and evoked potentials findings with clinical aspects and intrathecal synthesis of HTLV-I antibodies production on HTLV-I myelopathy (HAM). Patients were seropositive for HTLV-I by different assays and seronegative for HIV and VDRL. They h ... http://www.aegis.com/aidsline/1999/jul/a9970736.html File Name: a9970736.html, Size: 9KB, Last Modified: Wednesday, July 28, 1999 at 8:12:04 PM |
| 30. |
Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. (100%) Abstract: Distal symmetrical peripheral neuropathy is a common adverse experience in persons with HIV infection. This condition, which presents as a pain, numbness. burning and/or dysaethesia initially in the feet, is often multi-factorial in its origin. Nucleoside analogue rev ... http://www.aegis.com/aidsline/1999/jun/a9960671.html File Name: a9960671.html, Size: 10KB, Last Modified: Monday, June 28, 1999 at 8:12:04 PM |
|   |
|
|   |
|